GW

Goldenwell Biotech IncOOTC GWLL Stock Report

Last reporting period 30 Sep, 2023

Updated 21 Oct, 2024

Last price

Market cap $B

-100

Exchange

OOTC - OTC

GWLL Stock Analysis

GW

Uncovered

Goldenwell Biotech Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

-100

Dividend yield

Shares outstanding

96 B

Goldenwell Biotech Inc. is a development-stage nutraceutical company. The Company is primarily engaged in research and development, and commercialization of health care, bio-pharmaceuticals, bio-engineering drugs and cosmetic products. The Company is offering its products under two categories: polypeptide freeze-dried powder and solid tablets products. The Company’s products are JI MAI- Bovine Cardiac Vascular Active Peptide; Double Proline AG three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, and Sugar Master. Its Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which is made from healthy and fresh bovine cardiac vascular tissues as raw materials. The Sugar Master product ingredients include natural herbal polypeptides, concentrated and purified natural plant extracts and organic selenium complex.

View Section: Eyestock Rating